Supplies

Ended Purchase Order Awarded Last action

Contract number
W91YTZ19P0012
Awardee
Awarding agency
Obligated
$514,572

Award facts

Opportunity
Contract value 100% obligated
$514,572.15 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Fort Gordon, GA 30905, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 · FY23 base YR eamc YR4 0011783634-0002 $102,914
Exercise an Option P00010 · SAF OY 4 PR 11783634 $0
Other Administrative Action P00009 · MOD - PDS errors $0
Funding Only Action P00008 · FY22 ROF MOD immucor INC - PR 11642841 $102,914
Exercise an Option P00007 · FY22 OPT SAF immucor- OY3 - PR 11642841 $0
Funding Only Action P00006 · FY21 ROF and sect 889 $102,914
Exercise an Option P00005 $0
Funding Only Action P00004 $102,914
Other Administrative Action P00002 · Supplies adjust POP, option years and add revised reagent list. $0
Exercise an Option P00001 $0
Original award $102,914
Show all 11

About this award

Written by GovTribe AI ·

This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used.

Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the Department of Veterans Affairs, the Defense Health Agency, and the Indian Health Service. These have included blood reagents, test kits, diagnostic products, and analyzers to support blood typing, compatibility testing, and blood banking operations within federal healthcare facilities.

This award is likely part of Immucor's existing indefinite-delivery, indefinite-quantity (IDIQ) contract vehicles or blanket purchase agreements that facilitate the recurring procurement of critical transfusion and transplant medicine supplies. These established contract mechanisms allow the government to efficiently access Immucor's specialized medical products and associated maintenance services on an as-needed basis.

Quick answers

Who was awarded contract W91YTZ19P0012?

W91YTZ19P0012 was awarded to Immucor Inc. by Medical Command (Department of the Army) on October 19, 2018.

How much is contract W91YTZ19P0012 worth?

The government has obligated $514,572 on W91YTZ19P0012.

Which agency awarded contract W91YTZ19P0012?

Medical Command (Department of the Army) awarded W91YTZ19P0012, with funding from Defense Health Agency (Department of Defense).

Was contract W91YTZ19P0012 competed?

The extent of competition for W91YTZ19P0012 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login